140 related articles for article (PubMed ID: 22577971)
1. Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study.
El-Galaly TC; Kristensen SR; Overvad K; Steffensen R; Tjønneland A; Severinsen MT
J Thromb Haemost; 2012 Oct; 10(10):2191-3. PubMed ID: 22577971
[No Abstract] [Full Text] [Related]
2. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism.
Severinsen MT; Overvad K; Johnsen SP; Dethlefsen C; Madsen PH; Tjønneland A; Kristensen SR
Br J Haematol; 2010 Apr; 149(2):273-9. PubMed ID: 20148880
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analyses.
Lowe GD
J Thromb Haemost; 2012 Oct; 10(10):2186-8. PubMed ID: 22888854
[No Abstract] [Full Text] [Related]
5. Etiology of venous thrombosis: the need for small original studies.
Rosendaal FR
J Thromb Haemost; 2012 Oct; 10(10):2189-90. PubMed ID: 23025411
[No Abstract] [Full Text] [Related]
6. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
9. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
[No Abstract] [Full Text] [Related]
10. Risk factors and clinical presentation of venous thromboembolism according to the age of relatives of patients with factor V Leiden.
Couturaud F; Leroyer C; Mottier D;
Thromb Haemost; 2008 Apr; 99(4):793-4. PubMed ID: 18392344
[No Abstract] [Full Text] [Related]
11. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
[TBL] [Abstract][Full Text] [Related]
13. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
[TBL] [Abstract][Full Text] [Related]
14. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
[No Abstract] [Full Text] [Related]
15. Oral contraceptives, ABO blood types and thromboembolism.
Ambrus JL
CMAJ; 2013 Nov; 185(17):1526. PubMed ID: 24247436
[No Abstract] [Full Text] [Related]
16. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
17. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.
Couturaud F; Leroyer C; Julian JA; Kahn SR; Ginsberg JS; Wells PS; Douketis JD; Mottier D; Kearon C
Chest; 2009 Dec; 136(6):1537-1545. PubMed ID: 19592474
[TBL] [Abstract][Full Text] [Related]
18. Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.
Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
Georgian Med News; 2014 Feb; (227):93-7. PubMed ID: 24632656
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
[TBL] [Abstract][Full Text] [Related]
20. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies.
Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
